• No se han encontrado resultados

Systematic assessment of fluid responsiveness during early septic shock resuscitation: secondary analysis of the ANDROMEDA SHOCK trial

N/A
N/A
Protected

Academic year: 2020

Share "Systematic assessment of fluid responsiveness during early septic shock resuscitation: secondary analysis of the ANDROMEDA SHOCK trial"

Copied!
9
0
0

Texto completo

Loading

Figure

Fig. 1 Achievement of resuscitation endpoints during the intervention period according to fluid responsiveness status at baseline
Table 2 Resuscitation therapies during the 8-h intervention period
Fig. 2 a, b Evolution of fluid responsiveness during protocolized resuscitation, according to fluid responsiveness status at baseline

Referencias

Documento similar

Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports..

Clinical information system (CIS); Intensive care unit (ICU); Predicted body weight (PBW); Acute respiratory distress syndrome (ARDS); Tidal volume (TV); Mechanical ventilation

Porcine reproductive and respiratory syndrome virus (PRRSV) infection is one 36.. of the major health problems for the swine

Study of combination of nanoherbal andaliman ( Zanthoxylum acanthopodium ) and Extra Virgin Olive Oil (EVOO) effects in the expression of Malondialdehyde (MDA), Heat

reports receiving grant support paid to the institution and fees for serving on a steering committee for the ODYSSEY OUTCOMES trial (Evaluation of Cardiovascular Outcomes After an

In the European Community Respiratory Health Survey (ECRHS), in a previous analysis the assessment of the association between home outdoor NO2 (as a surrogate of traffic) and

Methods Using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017, we estimated the prevalence, morbidity, and mortality attributable to

Early intervention with intravenous (IV) metoprolol before reperfusion (METOCARD-CNIC [Effect of Meto- prolol in Cardioprotection During an Acute Myocardial Infarction] trial)